<ARTICLE> 5 <LEGEND> This Schedule contains summary financial information extracted from (a) the Balance Sheet and Statement of Operations filed as part of the Quarterly Report on Form 10-Q and is qualified in its entirety by reference to such (b) Report on Form 10-Q. </LEGEND> <CIK> 0000792641 <NAME> Bio-Reference Laboratories, Inc. <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> OCT-31-2000 <PERIOD-END> JUL-31-2000 <CASH> 1,056,162 <SECURITIES> 0 <RECEIVABLES> 22,218,261 <ALLOWANCES> 22,789,956 <INVENTORY> 650,290 <CURRENT-ASSETS> 24,403,167 <PP&E> 5,578,768 <DEPRECIATION> 3,720,224 <TOTAL-ASSETS> 36,897,854 <CURRENT-LIABILITIES> 21,988,677 <BONDS> 15,915,079 <PREFERRED-MANDATORY> 0 <PREFERRED> 60,408 <COMMON> 81,405 <OTHER-SE> 24,358,045 <TOTAL-LIABILITY-AND-EQUITY> 36,897,854 <SALES> 48,487,299 <TOTAL-REVENUES> 48,487,299 <CGS> 27,073,690 <TOTAL-COSTS> 47,533,919 <OTHER-EXPENSES> 1,126,300 <LOSS-PROVISION> 6,494,240 <INTEREST-EXPENSE> 1,184,060 <INCOME-PRETAX> (172,920) <INCOME-TAX> 0 <INCOME-CONTINUING> (172,920) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (172,920) <EPS-BASIC> (.02) <EPS-DILUTED> (.02)